- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 04-09-2025: Press Release
04-09-2025 | 03:49 pm
04-09-2025 | 03:49 pm
Zydus partners with Synthon for exclusive U.S. licensing and supply of generic ZEPOSIA® (Ozanimod Capsules), targeting multiple sclerosis and ulcerative colitis. This opens a USD 637 million market opportunity, boosting Zydus's presence in key therapeutic areas.
No comments yet. Be the first to comment!